56 filings
8-K
FULC
Fulcrum Therapeutics Inc
27 Feb 24
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:01am
8-K
FULC
Fulcrum Therapeutics Inc
7 Nov 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:02am
8-K
FULC
Fulcrum Therapeutics Inc
2 Oct 23
Departure of Directors or Certain Officers
4:01pm
8-K
FULC
Fulcrum Therapeutics Inc
22 Aug 23
Regulation FD Disclosure
7:01am
8-K
FULC
Fulcrum Therapeutics Inc
3 Aug 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:05am
8-K
jyciij qeg1kyzh
10 Jul 23
Entry into a Material Definitive Agreement
5:06pm
8-K
vey8h87q
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
570wbz
15 May 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:06am
8-K
uwei1
5 Apr 23
Departure of Directors or Certain Officers
8:13am
8-K
khg46nibx fcz7ava4
9 Mar 23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results
7:14am
8-K
ar68wtpd219oow1s6bm
18 Jan 23
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
5:12pm
8-K
w4vz o98k
17 Jan 23
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
4:53pm
8-K
q2lvgudmkloj4kjha0yj
4 Jan 23
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
7:12am
8-K
gkzy7t167wn2
8 Nov 22
Fulcrum Therapeutics Announces Recent Business Highlights
7:36am
8-K
luv1x4g6d 0gs
19 Oct 22
Departure of Directors or Certain Officers
4:06pm
8-K
znkns6izt0g2
23 Aug 22
Other Events
4:58pm
8-K
cw1tww u1v53
16 Aug 22
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
5:59pm
8-K
90x 8tsvqbd
11 Aug 22
Departure of Directors or Certain Officers
7:05am
8-K
gcqlgd1
11 Aug 22
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results
7:02am
8-K
f2gx8fyy11qkfal4oyg
11 Jul 22
Departure of Directors or Certain Officers
5:09pm